Beth Burgwyn Fuchs
Beth Burgwyn Fuchs
Assistant Professor, Brown University/Rhode Island Hospital
Verified email at
Cited by
Cited by
Antifungal chemical compounds identified using a C. elegans pathogenicity assay
J Breger, BB Fuchs, G Aperis, TI Moy, FM Ausubel, E Mylonakis
PLoS pathogens 3 (2), e18, 2007
Methods for using Galleria mellonella as a model host to study fungal pathogenesis.
BB Fuchs, E O’brien, JB Khoury, E Mylonakis
Virulence 79, 2362-71, 2010
Molecular and nonmolecular diagnostic methods for invasive fungal infections
M Arvanitis, T Anagnostou, BB Fuchs, AM Caliendo, E Mylonakis
Clinical microbiology reviews 27 (3), 490-526, 2014
Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform
G Tegos, T Dai, BB Fuchs, JJ Coleman, RA Prates, C Astrakas, ...
Frontiers in microbiology 3, 120, 2012
Ex vitro composite plants: an inexpensive, rapid method for root biology
TCG Collier R, Fuchs BB, Walter N, Kevin Lutke W
Plant Journal 43 (3), 449-457, 2005
Our paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathways
BB Fuchs, E Mylonakis
Eukaryotic cell 8 (11), 1616-1625, 2009
A new class of synthetic retinoid antibiotics effective against bacterial persisters
W Kim, W Zhu, GL Hendricks, D Van Tyne, AD Steele, CE Keohane, ...
Nature 556 (7699), 103-107, 2018
Prokaryote–eukaryote interactions identified by using Caenorhabditis elegans
AY Peleg, E Tampakakis, BB Fuchs, GM Eliopoulos, RC Moellering, ...
Proceedings of the National Academy of Sciences 105 (38), 14585-14590, 2008
Using non-mammalian hosts to study fungal virulence and host defense
BB Fuchs, E Mylonakis
Current opinion in microbiology 9 (4), 346-351, 2006
Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain
G Aperis, BB Fuchs, CA Anderson, JE Warner, SB Calderwood, ...
Microbes and infection 9 (6), 729-734, 2007
Antimicrobial Photodynamic Inactivation Inhibits Candida albicans Virulence Factors and Reduces In Vivo Pathogenicity
IT Kato, RA Prates, CP Sabino, BB Fuchs, GP Tegos, E Mylonakis, ...
Antimicrobial agents and chemotherapy 57 (1), 445-451, 2013
Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi
NR Cohen, RVV Tatituri, A Rivera, GFM Watts, EY Kim, A Chiba, ...
Cell host & microbe 10 (5), 437-450, 2011
Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus
R Rajamuthiah, BB Fuchs, AL Conery, W Kim, E Jayamani, B Kwon, ...
PloS one 10 (4), e0124595, 2015
Role of filamentation in Galleria mellonella killing by Candida albicans
BB Fuchs, J Eby, CJ Nobile, JB El Khoury, AP Mitchell, E Mylonakis
Microbes and infection 12 (6), 488-496, 2010
Susceptibility of Cryptococcus neoformans to Photodynamic Inactivation Is Associated with Cell Wall Integrity
BB Fuchs, GP Tegos, MR Hamblin, E Mylonakis
Antimicrobial agents and chemotherapy 51 (8), 2929-2936, 2007
Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus
R Rajamuthiah, BB Fuchs, E Jayamani, Y Kim, J Larkins-Ford, A Conery, ...
PloS one 9 (2), e89189, 2014
Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae
ACR Souza, BB Fuchs, HMS Pinhati, RA Siqueira, F Hagen, JF Meis, ...
Antimicrobial agents and chemotherapy 59 (10), 6581-6587, 2015
Polymerase chain reaction–based assays for the diagnosis of invasive fungal infections
TK Kourkoumpetis, BB Fuchs, JJ Coleman, A Desalermos, E Mylonakis
Clinical infectious diseases 54 (9), 1322-1331, 2012
Selecting an invertebrate model host for the study of fungal pathogenesis
A Desalermos, BB Fuchs, E Mylonakis
PLoS pathogens 8 (2), e1002451, 2012
Selecting an invertebrate model host for the study of fungal pathogenesis
A Desalermos, BB Fuchs, E Mylonakis
PLoS pathogens 8 (2), e1002451, 2012
The system can't perform the operation now. Try again later.
Articles 1–20